George Adel: Advancing Stroke Management at El Mabara Hospital Through Collaborative ICU Engagement
George Adel, Product Specialist at EVER Pharma (Africa), shared on LinkedIn:
”When you position yourself as a scientific resource rather than just a representative, you don’t just participate in the market you help shape it.
Today at El Mabara Hospital, it was all about partnering with the ICU team to elevate stroke management.
By aligning the clinical benefits of Cerebrolysin (right regimen) with the latest global guidelines, we aren’t just discussing a product, we are actively driving market growth and helping doctors optimize patient recovery.
A sincere thank you to Dr. Peter Wadie for always challenging me to grow and giving me the professional backing to execute these steps.
And to Dr. Sally Moheb, thank you for your encouragement and for always believing in my vision it really drives me to keep growing.”
Stay updated with Hemostasis Today.
-
Oct 2, 2026, 00:33Marwa Mostafa: Hemoglobinopathies – When Globin Genes Go Wrong
-
Oct 1, 2026, 23:46Behnood Bikdeli: Global Burden of Venous Thromboembolism
-
Oct 1, 2026, 23:46Sthanu Subramanian: Clinical Presentation, Risk Factors, Diagnosis, and Neuroimaging Findings in CVT
-
Oct 1, 2026, 23:45Martha Gulati: Oral MHT Is Associated With Increased Thrombotic Risk
-
Oct 1, 2026, 23:44Priya Sriskandarajah: HEMA-MED Trial Exploring Roginolisib Plus JAK Inhibitors in Myelofibrosis
-
Oct 1, 2026, 23:44Inge Vanhomwegen: Join Our Upcoming Webinar on D-dimer Testing
-
Oct 1, 2026, 23:43Bianca Rocca: Beyond API-CAT – Who Should Continue Anticoagulation, And for How Long?
-
Oct 1, 2026, 23:26Sara Gaafar Ibnauf Suliman: The Changing Role of Bariatric Surgery in the GLP-1 Era
-
Oct 1, 2026, 23:16Ahmed Reda: New Ferritin Cutoffs For Iron Deficiency – Ash 2026